logo

For the Inventor, By the Inventor

New Delhi, India

Mankind Pharma Ltd.


USPTO Granted Patents = 15

% Expired Patents = 20.0


Forward Citations = 5

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Anil Kumar (15 out of 28 patents)

silverMedal Santosh Kumar Rai (7 out of 9 patents)

bronzeMedal Rakesh Ishwar Patil (5 out of 5 patents)

4.  Jeevan Verma (5 out of 5 patents)

5.  P V S Narasimham (4 out of 4 patents)

6.  Amol Pandurang Gunjal (4 out of 4 patents)

7.  Himanshu Rai (4 out of 4 patents)

8.  Sazid Ali (4 out of 4 patents)

9.  Srinivasa Reddy Bapuram (4 out of 4 patents)

10.  Bhuwan Bhashkar (4 out of 5 patents)

11.  Puneet Kumar (3 out of 3 patents)

12.  Bharat Sharma (2 out of 2 patents)

13.  K S Hareen (2 out of 2 patents)

14.  Saurabh Kumar (2 out of 5 patents)

15.  Ankush Gupta (2 out of 2 patents)


15 patents:

1. 12667566 - Combination therapy of GPR119 agonists and DPP-4 inhibitors (2026-06-30),
2. 12516056 - Compounds for inhibition of janus kinase 1 (2026-01-06),
3. 11819577 - Fixed dose pharmaceutical composition of valsartan and sacubitril (2023-11-21),
4. 11707502 - Stable pharmaceutical composition of vasopressin (2023-07-25),
5. 11382866 - Fixed dose pharmaceutical composition of valsartan and sacubitril (2022-07-12),
6. 11318183 - Stable pharmaceutical composition of vasopressin (2022-05-03),
7. 11246862 - Process for the preparation of lifitegrast (2022-02-15),
8. 10954229 - GPR119 agonist compounds (2021-03-23),
9. 10919915 - Compounds as GPR119 agonists (2021-02-16),
10. 10752622 - GPR119 agonist compounds (2020-08-25),
11. 10526345 - Compounds as GPR119 agonists (2020-01-07),
12. 10377710 - Process for the preparation of considerably pure Silodosin (2019-08-13),
13. 10239833 - Intermediates, their process and use in preparation of selective α1-adrenoceptor antagonists, Silodosin (2019-03-26),
14. 10208030 - GPR119 agonist compounds (2019-02-19),
15. 10167271 - Fluoroquinolone carboxylic acid compounds and use thereof for the preparation of besifloxacin hydrochloride (2019-01-01),
Company Overview
Mankind Pharma Ltd. is a prominent pharmaceutical company based in New Delhi, India, specializing in the development and manufacturing of a wide range of healthcare products. The company focuses on various therapeutic areas, including cardiology, dermatology, and gynecology, and is committed to delivering high-quality medications and healthcare solutions. Mankind Pharma leverages advanced research and technology to enhance its product offerings, aiming to improve patient outcomes and accessibility in the healthcare sector.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Mankind Pharma Ltd. USPTO Patent Assignee Logo
15 Patents

#10 in New Delhi

#126 in India

#39,921 in the World

New Delhi, IN
New Delhi, India

Mankind Pharma Ltd.

Forward Citations = 5

25 inventors:

goldMedal Anil Kumar (15 out of 28 patents)

silverMedal Santosh Kumar Rai (7 out of 9 patents)

bronzeMedal Rakesh Ishwar Patil (5 out of 5 patents)

4.  Jeevan Verma (5 out of 5 patents)

5.  P V S Narasimham (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Mankind Pharma Ltd.. Retrieved from https://idiyas.com/company/mankind-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…